The authors found that the hepatic stellate cell (HSC)-specific knockout of m6A methyltransferase Mettl3 suppressed HSC activation and significantly alleviated liver fibrosis.
[Molecular Therapy]
The m6A Methyltransferase Mettl3 Deficiency Attenuates Hepatic Stellate Cell Activation and Liver Fibrosis
